Brookline Capital (NASDAQ:BCAC) announced in an 8-K this morning that its shareholders approved its combination with Apexigen at a special meeting July 27.
The filing did not include redemption figures, but the transaction also did not have a minimum cash condition beyond listing requirements. Brookline brought a $15 million PIPE alongside its trust in the deal and Lincoln Park also agreed to purchase up to $50 million of the combined entity’s stock in the two years following the transaction’s close.
Brookline traded below its estimated pro rata trust value of $10.22 throughout its July 25 redemption deadline, but has since soared to a close Wednesday at $10.75. Following the deal’s close, Apexigen is expected to trade on the Nasdaq under the symbol “APGN”.
The parties initially announced the $278 million combination on March 18. San Carlos, California-based Apexigen is developing a range of immunological cancer treatments with four currently in Phase II trials.
It announced the results of its Phase II trials to treat pancreatic cancer with its sotigalimab drug candidate in June.
ADVISORS
- Brookline Capital Markets is acting as capital markets advisor to Brookline Capital Acquisition Corp.
- Wedbush PacGrow is acting as exclusive strategic financial advisor to Apexigen.
- DLA Piper LLP (US) is serving as legal advisor to Brookline Capital Acquisition Corp.
- Wilson Sonsini Goodrich & Rosati, P.C. is serving as legal advisor to Apexigen.
Harvard Ave Acquisition Corporation (NASDAQ:HAVAU) has filed for a $250 million SPAC in a deal that significantly nudges upwards the prominence of D. Boral in the 2025 SPAC market to-date. Early 2025 filing activity has brought out some of the most biggest underwriters in SPACs, but, with Harvard Ave, the title of largest proposed SPAC...
UY Scuti (NASDAQ:UYSCU) has filed for a $50 million SPAC to search for a middle market target using the team’s largely China-based network of contacts. This is so far the smallest offering ask of any SPAC filing this year and in fact no other team has sought to form a SPAC smaller than $55 million since...
Nabors Energy Transition Corp. II (NASDAQ:NETD) has signed a definitive agreement to combine with energy management firm e2Companies at an enterprise value of $770 million, or 26.8x its 2024 revenue. Bonita Springs, Florida-based e2 produces smart generators that electrify off-grid sites and provide power optimizing services to reduce energy costs at high-demand locations. The combined...
In this special follow-up edition of the SPACInsider Podcast, we check back in with Dimitre Genov, Ed Kovary, and Nick Skibo, who last joined us at the end of Q3 2024, to assess the state of the SPAC market in 2025 and the key dynamics shaping the landscape. Our panel brings together perspectives from across...
Texas Ventures Acquisition III Corp. (NASDAQ:TVACU) became the third SPAC to file for an IPO with Cohen & Company in a row Monday morning, but it has some distinct differences from its cousin SPACs on terms. While Cohen’s other recent pair Real Asset Acquisition Corp. (NASDAQ:RAAQU) and Digital Asset Acquisition Corp. (NASDAQ:DAAQU) have initially asked...